HK1112928A1 - Cspcna isoform modifications and uses thereof - Google Patents

Cspcna isoform modifications and uses thereof

Info

Publication number
HK1112928A1
HK1112928A1 HK08108633.8A HK08108633A HK1112928A1 HK 1112928 A1 HK1112928 A1 HK 1112928A1 HK 08108633 A HK08108633 A HK 08108633A HK 1112928 A1 HK1112928 A1 HK 1112928A1
Authority
HK
Hong Kong
Prior art keywords
cspcna isoform
modifications
cspcna
disclosed
isoform modifications
Prior art date
Application number
HK08108633.8A
Other languages
English (en)
Inventor
Derek J Hoelz
Robert J Hickey
Linda H Malkas
Original Assignee
Univ Indiana Res & Tech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Indiana Res & Tech Corp filed Critical Univ Indiana Res & Tech Corp
Publication of HK1112928A1 publication Critical patent/HK1112928A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Insulating Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK08108633.8A 2005-06-27 2008-08-05 Cspcna isoform modifications and uses thereof HK1112928A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69415905P 2005-06-27 2005-06-27
PCT/US2006/024774 WO2007002574A2 (en) 2005-06-27 2006-06-26 Cspcna isoform modifications and uses thereof

Publications (1)

Publication Number Publication Date
HK1112928A1 true HK1112928A1 (en) 2008-09-19

Family

ID=37116243

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08108633.8A HK1112928A1 (en) 2005-06-27 2008-08-05 Cspcna isoform modifications and uses thereof

Country Status (12)

Country Link
US (2) US7932023B2 (xx)
EP (1) EP1899373B1 (xx)
JP (1) JP5090344B2 (xx)
CN (1) CN101258161A (xx)
AT (1) ATE504598T1 (xx)
AU (1) AU2006261856B2 (xx)
BR (1) BRPI0611703A2 (xx)
CA (1) CA2612695A1 (xx)
DE (1) DE602006021178D1 (xx)
EA (1) EA013109B1 (xx)
HK (1) HK1112928A1 (xx)
WO (1) WO2007002574A2 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8653039B2 (en) 2006-02-17 2014-02-18 Robert J. Hickey Peptide based inhibition of caPCNA interaction in cancer
EP2328602A2 (en) 2008-07-24 2011-06-08 Indiana University Research and Technology Corporation Cancer peptide therapeutics
US20120258482A1 (en) * 2009-10-09 2012-10-11 Indiana University Research And Technology Corporation Pcna methyltransferase
US8455200B2 (en) 2009-10-15 2013-06-04 Traxxsson, Llc Measurement of PKA for cancer detection
BR112013024357A2 (pt) * 2011-03-23 2016-12-20 Univ Indiana Res & Tech Corp agentes terapêuticos anticancerígenos
US10420840B2 (en) * 2015-04-10 2019-09-24 Rll, Llc Anticancer therapeutic agents
TWI825066B (zh) * 2018-02-01 2023-12-11 美商再生元醫藥公司 治療性單株抗體之品質屬性的定量及模型化

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7294471B2 (en) * 2002-02-27 2007-11-13 Cskeys, Llc Method for purifying cancer-specific proliferating cell nuclear antigen

Also Published As

Publication number Publication date
ATE504598T1 (de) 2011-04-15
US7932023B2 (en) 2011-04-26
WO2007002574A3 (en) 2007-05-03
CA2612695A1 (en) 2007-01-04
US20090061432A1 (en) 2009-03-05
WO2007002574A2 (en) 2007-01-04
AU2006261856A1 (en) 2007-01-04
JP5090344B2 (ja) 2012-12-05
EA200800144A1 (ru) 2008-06-30
CN101258161A (zh) 2008-09-03
EP1899373B1 (en) 2011-04-06
EA013109B1 (ru) 2010-02-26
US20110195510A1 (en) 2011-08-11
EP1899373A2 (en) 2008-03-19
BRPI0611703A2 (pt) 2011-12-20
JP2008547034A (ja) 2008-12-25
DE602006021178D1 (de) 2011-05-19
AU2006261856B2 (en) 2012-07-05

Similar Documents

Publication Publication Date Title
CA2755394C (en) Methods and compositions for cell-proliferation-related disorders
UA104459C2 (uk) Антитіла проти fgfr3 і способи їх застосування
MY173526A (en) Novel anti-?5?1 antibodies and uses thereof
PH12013502230A1 (en) Multispecific antibodies
MX2007008137A (es) Triazoloftalazinas como inhibidores de pde2.
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
WO2007081740A3 (en) Micrornarna-based methods and compositions for the diagnosis and treatment of solid cancers
BR112012014082A2 (pt) composições e métodos que compreendem variantes de protease
TW200732349A (en) Anti-OX40L antibodies and methods using same
HK1112928A1 (en) Cspcna isoform modifications and uses thereof
JO3118B1 (ar) تراكيب وطرق لبروتين c5 المتمم يستهدف الأجسام المضادة
WO2007136893A3 (en) Anti-fgf19 antibodies and methods using same
UA101478C2 (ru) Соединения, полезные как ингибиторы raf-киназы
HK1115590A1 (en) Triazolophthalazines
HK1129240A1 (en) Dna recombination junction detection
WO2008157697A3 (en) Copolymer assay
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
MX341064B (es) Variantes de la familia il-1.
ATE549638T1 (de) 13c-mr-bildgebung oder spektroskopie von zelltod
SG131082A1 (en) Fabp4 as marker for a toxic effect
WO2007002375A3 (en) Methods and compositions for analysis of microrna
TW200643177A (en) Method and kits for detecting genetically modified organism (GMO)
CL2007003659A1 (es) Kit de deteccion de microorganismos patogenos mediante pruebas de aliento.
ATE515558T1 (de) Schattierungszusammensetzung
IN2012DN01379A (xx)

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150626